文献速递妇科

机器人根治性宫旁切除术联合上段阴道切除及盆腔淋巴结清扫术用于筋膜外子宫切除术后隐匿性宫颈癌患者

Robotic Radical Parametrectomy With Upper Vaginectomy and Pelvic Lymphadenectomy in Patients With Occult Cervical Carcinoma After Extrafascial Hysterectomy.
PubMed 文献 · J Minim Invasive Gynecol · 2017-02-22

该回顾性队列研究纳入2007年1月至2015年12月在本机构因筋膜外子宫切除术后发现隐匿性宫颈癌而接受机器人根治性宫旁切除术联合上段阴道切除及盆腔淋巴结清扫术的17例患者,评估安全性和可行性,并综述15项研究共238例根治性宫旁切除术患者。结论认为该术式可行且安全,但无术前病理特征能预测辅助治疗需求或宫旁受累。

要点

  • 17例患者中发生2例术中并发症(1例肠损伤、1例膀胱损伤),1例需输血2单位。
  • 3例接受辅助放化疗(顺铂增敏),分别因阴道上段残留癌、宫旁及盆腔淋巴结阳性、盆腔淋巴结阳性。
  • 无患者复发,1例术后59.4个月死于不明原因。

核心结论

  • 机器人根治性宫旁切除术联合上段阴道切除及盆腔淋巴结清扫术是可行且安全的治疗选择;如文献所示,该术式有助于避免经验性辅助放化疗,但无病理特征能预测术后辅助治疗需求。

研究设计与样本

  • 回顾性队列研究及文献综述(加拿大任务组分类II-2),研究机构为北卡罗来纳大学教堂山分校妇产科。
  • 纳入2007年1月至2015年12月在本机构因筋膜外子宫切除术后发现隐匿性宫颈癌而接受机器人根治性宫旁切除术联合上段阴道切除及盆腔淋巴结清扫术的全部患者,共17例。
  • 同时综述文献中关于隐匿性宫颈癌根治性宫旁切除术的研究,分析15项研究共238例患者。

主要发现

  • 17例患者中发生2例术中并发症,包括1例肠损伤和1例膀胱损伤;1例患者需输血2单位。
  • 3例患者接受辅助放化疗(顺铂增敏),其中1例阴道上段残留癌、1例宫旁及盆腔淋巴结阳性、1例盆腔淋巴结阳性。
  • 无患者出现复发,1例患者在术后59.4个月死于不明原因。
  • 文献综述的238例患者中,无特定术前病理特征能预测结局、辅助治疗需求或宫旁受累。

临床怎么用

  • 原文结论认为机器人根治性宫旁切除术联合上段阴道切除及盆腔淋巴结清扫术是可行且安全的治疗选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To confirm the safety and feasibility outcomes of robotic radical parametrectomy and pelvic lymphadenectomy and compare the clinicopathological features of women requiring adjuvant treatment with the historical literature. DESIGN: Retrospective cohort study and review of literature (Canadian Task Force classification II-2). SETTING: Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill. PATIENTS: All patients who underwent robotic radical parametrectomy with upper vaginectomy (RRPV), and pelvic lymphadenectomy for occult cervical cancer discovered after an extrafascial hysterectomy at our institution between January 2007 and December 2015. INTERVENTIONS: RRPV and pelvic lymphadenectomy for occult cervical cancer discovered after an extrafascial hysterectomy. We also performed a literature review of the literature on radical parametrectomy after occult cervical carcinoma. MEASUREMENTS AND MAIN RESULTS: Seventeen patients with invasive carcinoma of the cervix discovered after extrafascial hysterectomy underwent RRPV with bilateral pelvic lymphadenectomy. There were 2 intraoperative complications, including 1 bowel injury and 1 bladder injury. One patient required a blood transfusion of 2 units. Three patients underwent adjuvant treatment with chemoradiation with radiation-sensitizing cisplatin. One of these patients had residual carcinoma on the upper vagina, 1 patient had positive parametria and pelvic nodes, and 1 patient had positive pelvic lymph nodes. No patients experienced recurrence, and 1 patient died from unknown causes at 59.4 months after surgery. We analyzed 15 studies reported in the literature and found 238 women who underwent radical parametrectomy; however, no specific preoperative pathological features predicted outcomes, the need for adjuvant treatment, or parametrial involvement. CONCLUSION: RRPV is a feasible and safe treatment option. As reflected in the literature, RRPV can help avoid empiric adjuvant chemoradiation; however, no pathological features predict the need for adjuvant treatment after surgery.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Tran AQ, Sullivan SA, Gehrig PA, et al. Robotic Radical Parametrectomy With Upper Vaginectomy and Pelvic Lymphadenectomy in Patients With Occult Cervical Carcinoma After Extrafascial Hysterectomy. J Minim Invasive Gynecol. 2017. PMID: 28254677. doi:10.1016/j.jmig.2017.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。